GlaxoSmithKline has been criticised for not raising the alarm quicker over the suicide risk associated with its antidepressant Seroxat, when used by young people.
Read More...
Read the complete post at http://www.communitycare.co.uk/blogs/mental-health/2008/03/seroxat-company-criticised.html